Market open
ESSA Pharma/$EPIX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ESSA Pharma
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
Ticker
$EPIX
Sector
Trading on
Industry
Biotechnology
Headquarters
Vancouver, Canada
Employees
35
Website
ESSA Pharma Metrics
BasicAdvanced
$78M
-
-$0.64
1.62
-
Price and volume
Market cap
$78M
Beta
1.62
52-week high
$11.67
52-week low
$1.40
Average daily volume
363K
Financial strength
Current ratio
38.642
Quick ratio
38.45
Long term debt to equity
0.165
Total debt to equity
0.264
Management effectiveness
Return on assets (TTM)
-15.52%
Return on equity (TTM)
-21.12%
Valuation
Price to book
0.63
Price to tangible book (TTM)
0.63
Price to free cash flow (TTM)
-3.43
Growth
Earnings per share change (TTM)
6.92%
3-year earnings per share growth (CAGR)
-12.32%
What the Analysts think about ESSA Pharma
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ESSA Pharma stock.
ESSA Pharma Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ESSA Pharma Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ESSA Pharma News
AllArticlesVideos
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ESSA Pharma Inc. (EPIX)
GlobeNewsWire·2 hours ago
Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Business Wire·3 hours ago
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of ESSA Pharma Inc. (EPIX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
GlobeNewsWire·4 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ESSA Pharma stock?
ESSA Pharma (EPIX) has a market cap of $78M as of January 27, 2025.
What is the P/E ratio for ESSA Pharma stock?
The price to earnings (P/E) ratio for ESSA Pharma (EPIX) stock is 0 as of January 27, 2025.
Does ESSA Pharma stock pay dividends?
No, ESSA Pharma (EPIX) stock does not pay dividends to its shareholders as of January 27, 2025.
When is the next ESSA Pharma dividend payment date?
ESSA Pharma (EPIX) stock does not pay dividends to its shareholders.
What is the beta indicator for ESSA Pharma?
ESSA Pharma (EPIX) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.